KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Novartis Ag (NVS) Equity Average (2018 - 2025)

Novartis Ag (NVS) has disclosed Equity Average for 8 consecutive years, with $45.1 billion as the latest value for Q4 2025.

  • Quarterly Equity Average fell 0.68% to $45.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45.1 billion through Dec 2025, down 0.68% year-over-year, with the annual reading at $45.1 billion for FY2025, 0.68% down from the prior year.
  • Equity Average hit $45.1 billion in Q4 2025 for Novartis Ag, down from $45.4 billion in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $63.6 billion in Q4 2022 to a low of $33.2 billion in Q4 2021.
  • Historically, Equity Average has averaged $48.1 billion across 5 years, with a median of $45.4 billion in 2024.
  • Biggest five-year swings in Equity Average: skyrocketed 1192.87% in 2021 and later decreased 16.56% in 2023.
  • Year by year, Equity Average stood at $33.2 billion in 2021, then skyrocketed by 91.63% to $63.6 billion in 2022, then fell by 16.56% to $53.1 billion in 2023, then fell by 14.41% to $45.4 billion in 2024, then dropped by 0.68% to $45.1 billion in 2025.
  • Business Quant data shows Equity Average for NVS at $45.1 billion in Q4 2025, $45.4 billion in Q4 2024, and $53.1 billion in Q4 2023.